Structure-based design of 5′-substituted 1,2,3-triazolylated oseltamivir derivatives as potent influenza neuraminidase inhibitors

Pengfei Wang(Chinese Academy of Sciences), Xuebing Li(Tianjin Medical University General Hospital), Jianxun Qi(Chinese Academy of Sciences), Shanshan Zhang(Broad Institute), Chenning Li(Chinese Academy of Sciences), Babayemi Olawale Oladejo(Federal University of Technology), Xun Lv(Chinese Academy of Sciences), Lifeng Fu(Chinese Academy of Sciences)
RSC Advances
January 1, 2021
Cited by 14


Related Papers